Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

(2010) David Groheux et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

(2010) Pierre Heudel et al.   International Journal of Clinical Oncology

18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis

(2010) J. R. Osborne et al.   JOURNAL OF NUCLEAR MEDICINE

The evolving role of PET/CT in breast cancer

(2010) David Groheux et al.   NUCLEAR MEDICINE COMMUNICATIONS

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer

(2009) A. Gil-Rendo et al.   BRITISH JOURNAL OF SURGERY

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

(2009) E. Manie et al.   CANCER RESEARCH

Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients

(2009) Till A. Heusner et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

(2008) S. Ueda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters

(2007) Sandip Basu et al.   CANCER